Basal insulin peglispro beats glargine for glycemic control

For patients with type 2 diabetes, basal insulin peglispro (BIL) provides better glycemic control than insulin glargine, with increased triglycerides, aminotransferases, and liver fat content, according to a study published online in the journal Diabetes Care. Medical Xpress
Source: Society for Endocrinology - Category: Endocrinology Source Type: news